Emergent Biosolutions
EBS
EBS
290 hedge funds and large institutions have $2.8B invested in Emergent Biosolutions in 2021 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 109 increasing their positions, 109 reducing their positions, and 83 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
32% less capital invested
Capital invested by funds: $4.13B → $2.8B (-$1.32B)
60% less first-time investments, than exits
New positions opened: 33 | Existing positions closed: 83
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
Holders
290
Holding in Top 10
–
Calls
$11.4M
Puts
$15.8M
Top Buyers
| 1 | +$56M | |
| 2 | +$41.6M | |
| 3 | +$27.2M | |
| 4 |
Two Sigma Investments
New York
|
+$26.6M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$19.4M |
Top Sellers
| 1 | -$46.8M | |
| 2 | -$27.9M | |
| 3 | -$23M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$23M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$22.7M |